The availability of highly purified recombinant enzymes and model heteropolymeric nucleic acid substrates now allows more precise evaluation of the ribonuclease H (RNase H) activity associated with human immunodeficiency virus (HIV) reverse transcriptase. In addition to degrading the RNA-DNA replicative intermediate, this C-terminal domain of around 130 residues supports highly specialized events that cannot be complemented by host-coded enzymes during retrovirus replication. RNase H activity should therefore be considered a plausible candidatefortherapeutic intervention. Events during HIV replication requiring precise RNase H-mediated hydrolysis, the methodologies available to study these events, and their potential for therapeutic intervention are reviewed here.
Introduction
Despite the emergence of drug-resistant virus variants (Erickson & Burt, 1996) , DNA synthesis inhibitors remain one of the most effective means of combating human immunodeficiency virus (HIV) infection and the devastating consequences of AIDS. These agents act at early stages in replication, either by lodging themselves within the retrovirus polymerase to prevent phosphodiester bond synthesis (e.g. nevirapine; Grob et al., 1992) , or via incorporation into the nascent DNA chain to prevent continued synthesis owing to the absence of a 3' OH group (e.g. AZT, 3TC and ddC; Broder, 1990; Coates et al., 1992; Devineni & Gallo, 1995) . However, it should be stressed that the effectiveness of an antiviral agent can be realized at several steps throughout the replication cycle, since the sole requirement is that it prevents synthesis of a full-length, integration-competent, proviral DNA. In this respect, the ribonuclease H (RNase H) function of HIV reverse transcriptase (RT), despite documentation of its absolute requirement for HIV-1 replication (Schatz et az', 1989 (Schatz et az', , 1990a Tisdale et az', 1991) , has received surprisingly little attention. One advantage of assessing the DNA polymerase activity of HIV RT lies in the ease with which this can be achieved using partially purified recombinant enzymes. In contrast, evaluation of RNase H activity, via degradation of the RNA moiety of an RNA-DNA hybrid, requires purified enzymes to ensure that they are free of contamination by their highly active bacterial or cellular counterpart. Advances in purification technologies have largely solved these practical problems and made recombinant enzymes available in amounts allowing both biochemical and biophysical characterization . At the same time, the advent of methods for large scale RNA production, either through in vitro transcription or chemical synthesis, has seen the development of assay systems accurately mimicking events during HIV replication that require precise RNase H -rnediated hydrolysis. As these methods have become available, they have indicated that screening efforts directed at RNase H function may lack the selectivity necessary to reveal subtle alterations that have a profound effect on the efficiency of reverse transcription (Le . A more thorough understanding of HIV RNase H function as it pertains to retrovirus replication will therefore playa critical role in developing future therapeutic strategies. Fig. 1 summarizes briefly the retrovirus replication cycle, highlighting steps at which RNase H function is invoked (for a more detailed account of retrovirus replication, see Skalka & Goff, 1993; Weiss et al., 1985) . First or H strand DNA synthesis is initiated from a host-derived tRNA hybridized to the primer binding site (PBS) of the viral RNA genome and proceeds from there towards the 5' terminus. At the same time, the RNA component of the that imprecise removal of either primer would alter DNA sequences at the termini of the provirus, which are critical recognition elements for integration (Panganiban & Temin, 1983) . Furthermore, while a host-derived tRNA provides the appropriate 3' terminus for initiation of (-) strand synthesis, (+) strand synthesis requires the correct primer terminus to be created by the replicating enzyme, facilitated by resistance of the PPT to hydrolysis. Finally, although RNase H-mediated removal of donor RNA would appear sufficient to allow DNA strand transfer, this event is clearly sensitive to alterations to RNase H function that uncouple its distinct modes of hydrolysis (Cirino et al., 1995; Ghosh et al., 1995) . Before describing these events in more detail, the following section summarizes structural features of the RNase H domain ofHIV-1 RT and mechanisms of hydrolysis.
RNase H-mediated events in HIV replication

The HIV-1 RNase H domain
Structural features
The isolated HIV-1 RNase H domain was one of the first retroviral proteins to be crystallized, in 1991 (Davies et al., 1991) , and is compared with its Escherichia coli counterpart (Yang et al., 1990; Katayanagi et al., 1992 Katayanagi et al., , 1993 in Fig. 2 . Despite sharing only limited sequence homology, the structures of the two polypeptides are remarkably similar; each comprises a five-stranded mixed~-sheet surrounded by asymmetrically distributed a-helices. However, a significant difference between the bacterial and retroviral enzymes is evident in the region connecting a-helices B' and D'. While this is a simple five residue loop in the HIV-1 RNase H domain, the E. coli enzyme contains an additional a-helix (rx-C') and charge cluster region, which have been proposed to mediate nucleic acid binding (Davies etal., 1991) . Since the DNA polymerase domain of HIV-1 RT provides the majority of the nucleic acid binding site (Kohlstaedt et al., 1992; Jacobo-Molina et al., 1993; Rodgers et al., 1995) , the retroviral enzyme appears to have evolved to accommodate the nucleic acid duplex without a requirement for the 'basic protrusion' (Katayanagi et al., 1992 ) of E. coliRNase H. Surprisingly, despite their structural similarity, the isolated HIV-1 RNase H domain is essentially inactive (Becerra et al., 1990; Stammers et al., 1991; Davies et al., 1991) , although it does appear capable of weakly binding model RNA-DNA duplexes (Cirino et al., 1993) . During maturation of p66-p51 HIV-1 RT from the Gag-Pol precursor, a copy of the RNase H domain is excised from the p66-p66 homodimer (Wang etal., 1994) . However, since the position at which the appropriate p66 subunit is cleaved (Phe 440 -Tyr 441 ) lies within~-strand l' (Davies et al., 1991) , this would result in a truncated RNase H domain, suggesting this polypeptide would have no biological significance.
Ribonuclease H as a therapeutic target Although an intramolecular event is depicted here, intermolecularstrand switching is also possible. (e) Following the second strand transfer, DNA-dependent DNA polymerase activity completes synthesis of Hand (+) strands yielding a double-stranded proviral DNA. In HIV and related lentiviruses, initiation of (+) strand synthesis from the central PPT (cPPT) results in a (+) strand discontinuity. 
Removal of PPT primer
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Modes of RNase H-mediated hydrolysis
During (-) strand synthesis, RT traverses an RNA template containing a recessed DNA primer with a free 3/ OH. X-ray crystallography of a co-crystal of HIV-l RT and duplex DNA (Jacobo-Molina et al, 1993) suggests the primer 3/ OH serves to position the replicating enzyme, and in doing so permits the RNase H catalytic centre to cleave the template a fixed distance behind the polymerase active site. However, template hydrolysis appears not to be so precisely coordinated with DNA synthesis, but rather occurs on average once every 13-45 nucleotides (DeStefano et al, 1994) . As a consequence, RNA-DNA duplexes are generated wherein several short RNA fragments are recessed on a considerably longer DNA strand which does not provide a free 3/ OH. How then does the enzyme deal with this second form of RNA-DNA hybrid? Fig. 4 (a) illustrates a typical HIV-l RNase H hydrolysis profile, derived from a model RNA-DNA hybrid whose DNA component is recessed, providing clear evidence of two modes of hydrolysis in the absence of DNA synthesis. Location of the DNA polymerase active site over the DNA 3/ terminus results initially in endonucleolytic cleavage between template nucleotides -17 and -20 [in keeping with hydroxyl radical footprinting data of HIV-l replication complexes from Metzger et al. (1993) , the first template-primer base pair in the polymerase catalytic centre is designated -1]. Subsequent to this, the RNA template is degraded towards the primer terminus, with hydrolysis halting approximately 8 nucleotides upstream of this, i.e. at © 1997 International Medical Press Ltd activity (Schatz et al., 1989j Mizrahi et al., 1990 and HIV-l replication (Schatz et al., 1990a ,bj Tisdale et al., 1991 . Mutagenesis data with the RNase H domains of RT from HIV-l, equine infectious anaemia virus (EIAV; Rausch & Le ) and E. coli (Kashiwagi et al, 1996) suggest a fourth residue of the HIV-l enzyme, Asp549, may also participate in catalysis. According to the revised mechanism of Kashiwagi et al. (1996) , His539 of the retroviral RNase H, rather than Asp498, would serve as a general base (precedents for which are the enzymes DNase I and exonuclease III), while Asp549 would be involved in appropriately positioning the water molecule activated by His 539 for electrophilic attack (Fig. 3 ). The mechanism of Kashiwagi et al. (1996) assumes participation of a single metal ion, which has been clearly defined in the crystal structure of the bacterial enzyme (Katayanagi etal, 1992 (Katayanagi etal, , 1993 . While the equivalent residues of HIV-I RNase H could fulfill an equivalent role, identification of two divalent cations (albeit Mn++) in the isolated domain (Davies et al, 1991) raises the possibility of a two-metal ion catalytic mechanism, as has been proposed for the Klenow fragment of DNA polymerase (Beese & Steitz, 1991) .
E. coliRNase H
HIV-1 RNase H aE'
For clarity, the nomenclature of a-helices and~-strands suggested by Jacobo-Molina et 01. (1993) has been adopted for both structures. Note that the bacterial enzyme contains an extra a-helix (a-C) and extended loop, while this region is missing from HIV-1 RNase H (a short loop connects a-helices B' and D'). Residues proposed to participate in catalysis are indicated.
Highly conserved residues of the HIV-l RNase H domain include A sp 443, Glu 478 , Asp498 and His539, mutations of which have severe consequences for both RNase (1996) with mutants of the bacterial enzyme, and our own findings with equivalent mutants of HIV-1 and EIAV RT [Reusch & Le . Residues of the HIV-1 RNase H domain follow the single letter code, while the numbers in parentheses indicate the equivalent residue of the bacterial enzyme. Adapted from Kashiwagi et 0/. (1996) , with permission. template nucleotide -8. These two activities were initially classified as endonuclease and 3'~5' exonuclease (Schatz et al., 1990b) , although directional processing appears a more appropriate definition for the latter (Cirino et al.,
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Ribonuclease H as a therapeutic target 1995; Ghosh et al., 1995) . Despite discrepancies in nomenclature, RNase H-mecliated hydrolysis clearly appears to be a two-step process, the significance of which during DNA strand transfer will be dealt with later.
In the experiment shown in Fig. 4(a) , the RNA.template was labelled at its 5' terminus; labelling the identical substrate at the RNA 3' terminus would be predicted to reveal only the point of initial endonucleolytic cleavage, since the products of 3'~5' directional processing would lack radiolabel. In contrast, prolonged incubation of a 3' -labelled substrate with HIV-1 RT results in the appearance of extremely short oligoribonucleotides, suggestive of further template processing, but with the opposite directionality, i.e. towards the RNA template 3' terminus. The determinants of this unusual directionality were recently elucidated by DeStefano (1995) and Palaniappan et al. (1996) , who showed that RNase H activity is also controlled by association of the retroviral polymerase with the recessed RNA 5' terminus of an RNA-DNA hybrid. Under such conditions, endonucleolytic cleavage approximately 17 nucleotides upstream of the RNA 5' terminus is followed by a similar phase of directional processing. The data shown in Fig. 4(b) can then be interpreted by invoking two discrete processes, (i) DNA primer-and (ii) RNA template-directed hydrolysis. In an initial step, binding to 3' OH of the DNA primer is favoured. Combined endonuclease and directional processing activities will generate a 'gapped' substrate within which template nucleotides between approximately -20 and -8 have been removed, with the consequence that the RNA template now provides a 5' terminus. Reassociation of RT over the RNA 5' terminus leads to renewed endonucleolytic cleavage, which in the substrate shown in Fig. 4 would be in the immediate vicinity of the 3' label. RNA 5'-directed RNase H activity is not unique to the HIV-1 enzyme; recent studies in our laboratory have demonstrated a similar property with the p66-p51 EIAV enzyme (Rausch & Le Grice, 1997) . This model, while tentative, suggests RT may remove (+) RNA in a systematic, stepwise fashion, with a directionality opposite to that of (-) DNA synthesis. The potential role of such an activity in PPT selection is clearly worthy of further investigation.
Although by definition RNase H activity is directed against RNA-DNA hybrids, the RT of both HIV-1 and murine leukaemia virus (MuLV) have been shown to cleave double-stranded RNA (Ben Artzi et al., 1992a,b; Blain & Goff, 1993) . Originally defined as RNase D (Ben Artzi et al., 1992a) , this activity was subsequently redesignated RNase H* (Hostomsky et al., 1994) in order to distinguish it from prokaryotic RNase D, which participates in tRNA maturation (Deutscher, 1993) . In HIV, RNase H and RNase H* activities derive from a 
Specialized RNase H-mediated events
DNA strand transfer Fig. 1 shows that the retroviral replication machinery encounters the 5' terminus of the (+) RNA genome shortly after initiation of (-) strand synthesis, requiring nascent DNA to be transferred to the 3' end of the genome through either an inter-or intrastrand event. Telesnitsky et al. (1992) have demonstrated in vivo that MuLV replication is interrupted at this stage when placed under the r Ribonuclease H as a therapeutic torget control of an RNase H -deficient RT, and is accounted for by the inability of nascent DNA to dissociate from the undegraded donor RNA template. By taking advantage of synthetically prepared RNA templates mimicking the sequences of donor and acceptor RNAs, a model, twotemplate system was developed by Peliska & Benkovic (1992) to investigate the involvement of RNase H activity in (-) strand transfer. Once RT reaches the 5' terminus of the donor template, the last 'polymerization-dependent' endonucleolytic cleavage event occurs 17 nucleotides distal to this. Thereafter, a 'polymerization-independent' RNase H activity (formally analogous to the directional processing function described by Cirino et al., 1995; Ghosh et al., 1995) cleaves the residual RNA template to within 8 nucleotides of the 5' terminus. Concomitant with this switch in modes of RNase H hydrolysis is an increase in the efficiency with which nascent DNA is transferred to the recipient RNA template.
The efficiency of strand transfer as a function of the length of the residual donor RNA template (Peliska & Benkovic, 1992) suggests that DNA synthesis-dependent RNase H activity, i.e. cleavage 17 nucleotides behind the growing primer, might be insufficient to sustain this event. In fact, we have demonstrated this experimentally with several HIV-1 RT mutants. Evaluation of the RNase H mutant p66 E 478Qjp51 (Schatz et al., , 1990a in the presence of Mn" indicates that almost quantitative levels of polymerasedependent activity can be selectively restored (Cirino et al., 1995) . An equivalent phenotype has been noted when (i) residues Ser55LLeu560 are removed from the RNase H domain of the p66 subunit (p66Ll8/p51 RT; Ghosh et al., 1995) ; or (ii) 13 residues are removed from the 'non-catalytic' p51 subunit (mutant p66/p51~13; Jacques et al., 1994; Arts et al., 1996) . Although the exact mechanism underlying this uncoupling of synthesis-dependent and -independent activities remains to be established, in each case the inability to process the donor template as far as position -8 correlates with a severe reduction in strand transfer efficiency. The ability to mimic these events with 'allosteric' inhibitors which would interact with, and alter the geometry of, the RNase H domain (much in the same way as nevirapine imposes severe constraints on the p66 thumb sub domain to inhibit catalysis) should not be overlooked. However, a recurring theme of this review is that such therapeutic strategies can only be considered when the appropriate assays are available to evaluate this specialized event.
Selection of the plus-strand primers
At no time during reverse transcription is RNase H activity more critical than during selection and processing of (+) strand primers. While (-) strand synthesis is initiated The resulting RNA-DNA hybrid (ii) is purified and incubated with wild-type RT in the presence of dNTPs, one of which is rodiolobelled. (ii) RNase H activity digests the RNA-DNA replicative intermediatewith the exception of the PPT, which is extended into (+) DNA (iv). As the enzyme traverses the PPT RNA-(+) DNA junction, the PPT must be removed from nascent (+) DNA, although not necessarilyfrom residual (+) strand RNA at its 5' terminus. (b) (+) strand synthesis on HIV-l and EIAV genomes catalysed by their respective RTs. For each system, a DNA sequencing gel is used for localizing the PPT, whose sequence is given. Lanes designated '-' and '+' indicate whether nascent (+) strand DNAwas treated withNaOH to remove the PPT primer. Both enzymes have the ability to select, extend and remove the PPT primer in a single step, since the major (+) strand product is largely unaffected by alkali treatment. Figure 5 . An in vitro assay for selection, utilization and removal of the (+l strand PPT primers of HIV-l and EIAV from a host-derived tRNALys,3 annealed to viral RNA, (+) strand primers must be generated de novo by highly specific RNase H-mediated cleavage at the 3' terminus of the PPT in the (+) strand genome (Sorge & Hughes, 1982) . In HIV, PPTs located at the centre (cPPT) and at the 3' end of the genome (3' PPT) are utilized for (+) strand synthesis, the result of which is a (+) strand discontinuity at the centre of the double-stranded pre-integrative DNA (Charneau & Clavel, 1991; Charneau et a!., 1992; Hungnes et al., 1991 Hungnes et al., , 1992 . Furthermore, if cleavage at the 3' PPT is imprecise, the resulting DNA intermediate may contain inappropriate sequences at the 5' terminus of the long terminal repeat (LTR; Bowman et al., 1996) which would result in an abortive infection. While the requirement for RNase H in (+) strand primer selection has been established, the overall mechanism by which selection occurs remains to be elucidated. As illustrated in Fig. 1, (-) (1994) demonstrated that RNA fragments ranging in size from 8-20 nucleotides represent the RNase H hydrolysis products of RNA-dependent DNA synthesis, suggesting that the viral RNA genome may be extensively processed during (-) strand synthesis. It has also been shown that the endonuclease and directional processing RNase H activities can be invoked in the presence of DNA synthesis (Furfine & Reardon, 1991b; Peliska & Benkovic, 1992) . When examining RNase H cleavage events under conditions allowing a single round of DNA synthesis, DeStefano et al. (1994) determined that the polymerizing enzyme cleaved the RNA template an average of once every 13-45 nucleotides. This observation suggests that RNase H cleavage occurs either infrequently and at random during DNA synthesis, or is determined by sequence and/or structural features of the RNA template encountered by the replicating enzyme, which induce transient pausmg.
The latter is an intriguing possibility, as a short stretch of contiguous Us precedes the HIV central and 3' PPTs. The DNA counterparts of such homopolymeric stretches have been proposed to regulate gene expression through their ability to induce local distortion in the duplex (Koo eta!., 1986; Nelson et al, 1987) . Moreover, Charneau et al. (1994) have presented evidence that a similar sequence serves to halt HIV-1 RT at late stages of replication. If a scenario is invoked where HIV-1 RT was induced to pause upon encountering or copying the poly(U) sequence during (-) strand synthesis, the RNase H domain would be located within 1-2 nucleotides of the 3' terminus of the PPT, where cleavage is required to free the 3' OH for (+) strand synthesis. Such a correlation between pausing and 180 HIV 3' PPT selection by RT has been demonstrated (Williams et al., 1990) ; however, a comparative analysis of pausing during (-) strand synthesis revealed no consistent pattern of pausing in the vicinity of the HIV central PPT OW Rausch & SFJ Le Grice, unpublished results). Furthermore, while coordination of (-) strand synthesis and HIV-1 PPT selection can be demonstrated in vitro, it does not appear to be a prerequisite to correct (+) strand primer selection, as RT provided in trans to PPT-containing RNA-DNA hybrids correctly liberates the 3' OH (Powell & Levin, 1996) . Hence, the extent to which (-) strand synthesis and PPT selection are coupled in vivo remains unknown.
In contrast to other DNA polymerases, retroviral RT selectively favours initiation of DNA synthesis from PPT primers over random RNA primers (Huber & Richardson, 1990; Powell & Levin, 1996) However, the 15-20 nucleotide PPT must not only direct initiation, but accurate cleavage at its 3' terminus to liberate nascent (+) strand DNA. A comparison of the 3' termini of PPT sequences from several retroviruses (Rattray & Champoux, 1989) suggests conservation of a poly(rA)-poly(rG) motif. Mutational analysis of the MuLV PPT demonstrated that RNase H cleavage by MuLV RT consistently occurs 6 nucleotides downstream ofthis poly(rA)-poly(rG) junction (Rattray & Champoux, 1989) . When the location of this junction is altered relative to the cleavage site at the 3' end of the PPT, the principle site of RNase H cleavage is displaced by 1-2 nucleotides, and cleavage is less specific. It has also been demonstrated that priming efficiency by HIV-1 RT is unaffected by alterations of the PPT sequence 5' to the poly(rA)-poly(rG) junction, yet is dramatically reduced when the poly(rG) sequence is disrupted (Powell & Levin, 1996) , suggesting that different regions within the PPT direct its selection and extension. Finally, it is becoming increasingly clear that an intimate structural relationship exists between RT and the cognate PPT of different retroviruses. For example, despite similarities between HIV and EIAV RT, which include similar subunit size and composition and greater than 40% sequence similarity, the two enzymes differ in their specificity and efficiency of PPT selection (Rausch & Le Grice, 1997) . Similar studies indicate that MuLV and HIV-1 RT differentially select the MuLV PPT (Pullen et al., 1993) . Furthermore, a mutational analysis of RT illustrated that eliminating 'polymerase-independent' RNase H activity manifests itself in altered cleavage immediately upstream of the PPT (Rausch & Le , while amino acid substitutions within the highly conserved 'primer grip' region of the polymerase domain affect both the efficiency and specificity of PPT selection and extension (MD Powell, M Ghosh, PS Jacques, KJ Howard, SJF Le Grice & JG Levin, unpublished results). Clearly, the dependence of (+) strand initiation on highly specific RNase H cleavage events renders this stage of reverse transcription highly sensitive to disruption and a potentially promising target for antiviral therapy.
Removal of (-) and (+) strand primers
Following initiation from the HIV-1 3' PPT, (+) strand synthesis continues over the nascent (-) strand DNA template, copying the U3, Rand U5 regions of the viral genome, as well as the 18 nucleotides comprising the 3' acceptor stem of the tRNALys,3 (-) strand primer. This segment of the (+) strand is designated (+) strand strongstop DNA, and contains a copy of the PBS sequence at its 3' terminus (Fig. 1) . The currently accepted notion is that the first modified residue of host-derived tRNA (Me S8A) provides the termination signal required to prevent the entire tRNA from being reverse-transcribed (Weiss et al., 1985) , although a recent report suggests that tRNA secondary structure may also playa role (Ben-Artzi et al., 1996) . To complete (+) strand synthesis, a second strandtransfer event is required through which nascent (+) strand DNA containing the PBS sequence is removed from the tRNA primer, allowing it to anneal with the PBS complement of the (-) strand DNA. During this process, tRNA must be removed by the RNase H activity of RT to facilitate its dissociation. Correct tRNA removal is required to define the 3' LTR terminus, which is a sequence element critical for recognition by the retroviral integration machinery (Panganiban & Temin, 1983) . While little is known about the timing and mechanism of tRNA removal, studies in HIV indicate that following completion of (+) strand strong-stop DNA synthesis, tRNA is cleaved intact, but at the penultimate ribonucleotide (Furfine & Reardon, 1991a; Pullen &Champollx, 1992; Smith & Roth, 1992) . The length of the PBS is equivalent to the spatial separation of the DNA polymerase and RNase H catalytic centres of HIV-1 RT (18 nucleotides), suggesting the replicating enzyme, transiently stalled at the first modified residue of tRNALys,3, is perfectly positioned for RNase H cleavage at the RNA-DNA junction. It is currently unclear why the enzyme does not excise the tRNA replication primer with the same precision used to remove the (+) strand PPT primer, especially in light of findings with the ROllS sarcoma virus enzyme, which indicate that the tRNA primer is precisely removed (Orner & Faras, 1982; Champoux et al., 1984) .
Involvement of nucleocapsid protein in RNase H-mediated events
Several roles have been ascribed to the gag-encoded nucleocapsid protein (NC) of HIV, including (i) destabilizing the tRNA replication primer to assist its annealing Antiviral Chemistry & Chemotherapy 8(3) Ribonuclease H as a therapeutic target to the PBS (Barat et al, 1989 (Barat et al, , 1993 ; (ii) promoting annealing of the dimeric retrovirus RNA genome (Tsuchihashi & Brown, 1994; Lapadat-Tapolsky et al., 1995) ; (iii) destabilization of intramolecular template duplexes to assist translocation of the replication machinery (Wu et ai., 1996) ; (iv) preventing abortive initiation from the 3' terminus of 'snap-back' structures on the RNA template (Li et al., 1996) ; and (v) acceleration of DNA strand transfer (Peliska et al., 1994; Rodriguez-Rodriguez et al., 1995) . The last of these possibilities is of particular interest, based on reports that the efficiency of (-) strand DNA transfer correlates with the ability of synthesis-independent, or directional processing RNase H activity to reduce the length of the residual donor RNA template from 17 to 8-9 nucleotides (Peliska et al., 1994) . Such observations raise the possibility that NC might enhance DNA strand transfer not by promoting dissociation and association of nascent DNA with the donor and acceptor templates, but rather by accelerating the rate at which the donor template is hydrolysed. Stated differently, an interaction of NC with RT in a manner which stimulates RNase H activity could produce the same result. This notion would be consistent with early reports that RNase H activity of HIV-1 RT is modulated in the presence of NC (Peliska et al., 1994) . Our own studies with HIV-1 RT mutants partially defective in RNase H function support this contention.
The selectively deleted HIV-1 RT mutant p66/p51Ll13 (Jacques et al., 1994) contains a 13 residue p51 deletion which results in loss of directional processing RNase H activity , concomitant with which is a severe reduction in (-) strand DNA transfer (Cameron et al., 1997) . However, both RNase H functions are restored when this mutant is incubated with NC, accompanying which is observed a marked increase in the efficiency of strand transfer. Based on the crystal structure of p66-p51 HIV-1 RT (Kohlstaedt et al., 1992; Jacobo-Molina et al., 1993; Rodgers et al., 1995) , the extreme C terminus of p51 (i.e. the connection subdomain) appears to extend towards, and possibly under its thumb subdomain, which in turn is in direct contact with the RNase H domain of p66. Truncating p51 at its C terminus appears to have architectural consequences for the geometry of its thumb, resulting in misalignment of the p66 RNase H domain. It is therefore feasible that NC interacts with the mutant heterodimer close to the p51 C terminus; a logical site of contact would be where a copy of the RNase domain was proteolytically excised during maturation of the p66-p66 homodimer (Wang et al., 1994) . Although further experimentation is necessary to understand better NC-mediated restoration of RNase H activity, our findings (Cameron et al., 1997) present an unexpected opportunity for development of therapeutic agents antagonizing this interaction.
Inhibitors and inhibition of HIV RNase H
It is unclear why a wealth of data on nucleoside and nonnucleoside-based inhibitors of DNA polymerase function of HlV RT should contrast with limited reports of inhibition of the C-terminal RNase H function of the same enzyme. This is particularly surprising in view of documentation that several unique steps of HlV replication (see Fig. 1 ) require highly specific RNase H-mediated hydrolysis. Although sulphated polyanions were demonstrated several years ago to inhibit RNase H function and HlV-1 replication (Moelling et a!., 1989) , it is likely that these compounds exert their effect by antagonizing the interaction of the surface glycoprotein gp120 with the CD4 receptor rather than having a direct influence on the replication machinery. Subsequent to this, illimaquinone, a secondary metabolite from the Red Sea sponge Smensopongia spp., was reported to be an effective RNase H inhibitor at concentrations which do not impair mammalian DNA polymerase (Loya et al., 1990) . Later in vitro mutagenesis data from the same group (Loya & Hizi, 1993) suggest the RNase H domain is probably not the primary target of this inhibitor, but rather the p66 thumb subdomain, based on resistance to inhibition following modification of Cys280. Although further data on illirnaquinone are unavailable, the data of Loya & Hizi (1993) While a particularly attractive feature ofHP 0.35 was the availability of a considerable amount of pharmacodynamic data on the parent drug, its further exploitation has not been reported. At mM concentrations, 3' -azido-S"deoxythymidine (AZT) monophosphate, a precursor of the DNA polymerase inhibitor AZT-triphosphate, has also been shown to inhibitHlV-1 RNase H (Tan et a!., 1991) . Since high concentrations of this anabolite can be achieved during AZT treatment, it has been proposed that this mechanism could in part account for the sensitivity of HIV to AZT.
More recently, Althaus et al. (1996) have reported that novemamines (substructures of the antibiotic novobiocin comprising the sugar noviose and a substituted coumarin residue) will inhibit RNase H activity in the range 25-75 flM. Although such compounds have been demonstrated to exist in an ionized, micellular form at the pH at which they are effective (pH 8.5), the observation that they are (i) inactive as DNA polymerase inhibitors at concentrations above 100 flM; and (ii) inhibit RNase H function of other retroviral enzymes, suggests their activity does not reflect 182 non-specific interaction with RT. The observation that these compounds exist in multiple physical states (protonated and deprotonated monomers, ionized micelles and protonated micelles) complicates identification of the active species, whose~, representing the sum of active and inactive species, may actually be lower than has been reported. Although confmnational evidence is currently unavailable, these authors have speculated that novenamines may interact with the substrate binding domain of RT which normally recognizes phosphate groups on the backbone of the RNA-DNA hybrid. Finally, nucleotide monomers and dimers have been shown by Allen et al. (1996) to inhibit HlV-1 RNase H at flM concentrations. These compounds could be subdivided into three groups, reflecting their ability to (i) inhibit preferentially RNase H activity of the structurally related heterodimers of HlV-1 and FlV without affecting DNA polymerase function; (ii) inhibit both DNA polymerase and RNase H function; and (iii) elicit broad spectrum activity against RNase H of retroviral, bacterial and cellular origin, without significantly affecting polymerase function of the retroviral enzyme. Currently, no mechanism has been forwarded for the inhibitory effect of these compounds.
An important issue for drug screening efforts is whether quantitative methods of assessing RNase H function may have indirectly influenced therapeutic efforts by virtue of their insensitivity to alterations in the mode of RNase H-mediated hydrolysis. We have shown RNase H activity can be subdivided into endonucleolytic and directional processing components, and that loss of the latter has severe consequences for the efficiency of DNA strand transfer (Cirino et al., 1995; Ghosh et al., 1995; Cameron et al., 1997) . Furthermore, while current dogma envisages the 3' terminus of nascent DNA as a critical determinant in RT positioning on an RNA-DNA hybrid and its subsequent hydrolysis, it is now clear that the 5' terminus of an RNA molecule recessed on a longer DNA fragment will direct equivalent events. RT mutants in our collection lacking directional processing function (under the control of DNA 3' and RNA 5' termini) have been shown to differ only slightly from wild-type enzyme when evaluated quantitatively on a randomly labelled RNA-DNA hybrid. Thus, as our efforts to identify novel classes of RNase H inhibitors progress, it will be important to introduce methods of qualitative evaluation which more accurately reflect important steps in HlV replication. Finally, alterations to subdomain geometry should not be excluded as a potential means of inhibiting RNase H function. The RNase H defect of the HlV-1 mutant p66/pS1i113 (Jacques et a!., 1994; Arts et al., 1996) reflects an alteration to the pS1 (i.e. RNase-free) subunit which alters the geometry of the p66 RNase H domain. 'Allosteric' inhibitors, which may bind in the vicinity of the RNase H domain to elicit a similar alteration in subdomain geometry, may therefore hold promise, providing the appropriate methodologies for assessing RNase H function are available.
